Abstract
Magnetically-assisted delivery of therapeutic agents to the site of interest, which is referred to as magnetic drug targeting, has proven to be a promising strategy in a number of studies. One of the key advantages over other targeting strategies is the possibility to control remotely the distribution and accumulation of the nanocarriers after parenteral administration. However, preparation of effective and robust magnetically responsive nanocarriers based on superparamagnetic iron oxide nanocrystals (SPIONs) still represents a great scientific challenge, since spatial guidance of individual SPIONs is ineffective despite the presence of high magnetic field gradient. A strategy to overcome this issue is the clustering of SPIONs to achieve sufficient magnetic responsiveness. In this mini-review, we address current and future strategies for the design and fabrication of magnetically responsive nanocarriers based on SPIONs for magnetically-targeted drug delivery, including the underlying physical requirements, the possibility of drug loading, and the control of drug release at the targeted site.
Keywords: Magnetic nanoparticles, nanoparticle clusters, magnetic drug delivery, iron oxide nanocrystals, SPION clusters, magnetic targeting, magnetic nanocarriers, magnetically-assisted delivery.
Current Medicinal Chemistry
Title:Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery
Volume: 24 Issue: 5
Author(s): Slavko Kralj, Tanja Potrc, Petra Kocbek, Silvia Marchesan and Darko Makovec
Affiliation:
Keywords: Magnetic nanoparticles, nanoparticle clusters, magnetic drug delivery, iron oxide nanocrystals, SPION clusters, magnetic targeting, magnetic nanocarriers, magnetically-assisted delivery.
Abstract: Magnetically-assisted delivery of therapeutic agents to the site of interest, which is referred to as magnetic drug targeting, has proven to be a promising strategy in a number of studies. One of the key advantages over other targeting strategies is the possibility to control remotely the distribution and accumulation of the nanocarriers after parenteral administration. However, preparation of effective and robust magnetically responsive nanocarriers based on superparamagnetic iron oxide nanocrystals (SPIONs) still represents a great scientific challenge, since spatial guidance of individual SPIONs is ineffective despite the presence of high magnetic field gradient. A strategy to overcome this issue is the clustering of SPIONs to achieve sufficient magnetic responsiveness. In this mini-review, we address current and future strategies for the design and fabrication of magnetically responsive nanocarriers based on SPIONs for magnetically-targeted drug delivery, including the underlying physical requirements, the possibility of drug loading, and the control of drug release at the targeted site.
Export Options
About this article
Cite this article as:
Kralj Slavko, Potrc Tanja, Kocbek Petra, Marchesan Silvia and Makovec Darko, Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666160813211736
DOI https://dx.doi.org/10.2174/0929867323666160813211736 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cannabinoid Receptors as Therapeutic Targets
Current Pharmaceutical Design Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Current Medicinal Chemistry The Generation and Antigen-Specificity of CD4+CD25+ Regulatory T Cells
Inflammation & Allergy - Drug Targets (Discontinued) Application of Kinase Inhibitors for Anti-aging Intervention
Current Pharmaceutical Design Anti-Nociceptive and Anti-Inflammatory Effects of Stem Bark Extract of <i>Ficus Capensis</i> Thunb (Moraceae) by Bioactivity Fractionation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Xanthomicrol: A Comprehensive Review of Its Chemistry, Distribution, Biosynthesis and Pharmacological Activity
Mini-Reviews in Medicinal Chemistry Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor
Current Topics in Medicinal Chemistry Proteasomal Inhibition: A Novel Pathway for Prevention of Atherosclerosis and Restenosis
Vascular Disease Prevention (Discontinued) Osteoarthritis - Current Insights in Pathogenesis, Diagnosis and Treatment
Current Rheumatology Reviews Recent Advancement in Natural Hyaluronidase Inhibitors
Current Topics in Medicinal Chemistry Treatment of Disability in Peripheral Arterial Disease: New Drugs
Current Drug Targets - Cardiovascular & Hematological Disorders Physicochemical and Biological Characterization of Anti-Endotoxin Peptides and Their Influence on Lipid Properties
Protein & Peptide Letters The Unique Inhibitory IgG Receptor--FcγRIIb
Protein & Peptide Letters Combination of Fenofibrate with Non-Statin Drug Regimens
Current Pharmaceutical Design Molecular Docking to Identify Associations Between Drugs and Class I Human Leukocyte Antigens for Predicting Idiosyncratic Drug Reactions
Combinatorial Chemistry & High Throughput Screening Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response
Current Cancer Drug Targets Extracellular Vesicles and Insulin Resistance: A Potential Interaction in Vascular Dysfunction
Current Vascular Pharmacology Monocyte and Macrophage Dysfunction as a Cause of HIV-1 Induced Dysfunction of Innate Immunity
Current Molecular Medicine